Video Experimental Relacionado
Updated: Jun 22, 2026

08:18
Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
STAT3 mitocondrial apoya la transformación oncogénica dependiente de Ras
Daniel J Gough1, Alicia Corlett, Karni Schlessinger
1Department of Pathology and New York University Cancer Institute, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.
Resumen
El transductor de señales y activador de la transcripción 3 (STAT3) apoya el cáncer impulsado por Ras. STAT3 es el estado de las cosas.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Investigación del cáncer Investigación del cáncer.
- Biología celular Biología celular.
Sus antecedentes:
- El transductor de señales y activador de la transcripción 3 (STAT3) es un factor de transcripción activado por fosforilación.
- STAT3 normalmente se transloca al núcleo para regular la expresión génica.
- Las oncoproteínas Ras son conductores conocidos de la transformación maligna.
Objetivo del estudio:
- Para investigar el papel de STAT3 en la transformación maligna mediada por Ras.
- Para determinar si se requiere la función nuclear canónica de STAT3 para la transformación Ras.
- Explorar las funciones no canónicas de STAT3 en el cáncer.
Principales métodos:
- Se utilizaron modelos celulares transformados Ras.
- Se emplean mutantes STAT3 con alteraciones en la fosforilación, la translocación nuclear o la unión al ADN.
- Investigó la localización de STAT3 utilizando técnicas de biología celular.
- Cambios metabólicos evaluados, incluida la glucólisis y la fosforilación oxidativa.
Principales resultados:
- La transformación mediada por Ras se vio afectada en ausencia de STAT3.
- Los mutantes STAT3 que carecían de funciones canónicas aún apoyaban la transformación Ras.
- STAT3 se encontró en las mitocondrias, independientemente de la translocación nuclear.
- Dirigir STAT3 exclusivamente a las mitocondrias facilitó la transformación Ras.
- Las vías metabólicas mitocondriales STAT3 moduladas asociadas con el cáncer.
Conclusiones:
- STAT3 juega un papel crucial en la transformación maligna mediada por Ras más allá de su actividad transcripcional nuclear.
- STAT3 posee una función no canónica dentro de las mitocondrias que apoya el metabolismo del cáncer.
- STAT3 mitocondrial contribuye directamente a la reprogramación metabólica esencial para la supervivencia y la proliferación de las células cancerosas.
Videos de Conceptos Relacionados
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...

